BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38295749)

  • 1. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
    Wang YB; Lv YF; Zhang Y; Wang W
    Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
    Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
    Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
    Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
    Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease.
    Wang W; Lv YF; Zhang YJ; Dong WJ; Zhang Y
    Stem Cell Res; 2020 Oct; 48():101937. PubMed ID: 32763824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
    Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
    Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease.
    Boeing A; Mavrommatis L; Daya NM; Zhuge H; Volke L; Kocabas A; Kneifel M; Athamneh M; Krause K; Südkamp N; Döring K; Theiss C; Roos A; Zaehres H; Güttsches AK; Vorgerd M
    Stem Cell Res; 2023 Oct; 72():103220. PubMed ID: 37839261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
    Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome.
    Doeser MC; Krygin J; Röpke A; Han D; Wedlich-Söldner R; Schöler HR; Pavenstädt H; Kim KP
    Stem Cell Res; 2022 Jul; 62():102826. PubMed ID: 35667217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
    Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two hiPSCs lines of two patients carrying truncating mutations in the dimerization domain of filamin C.
    Daya NM; Döring K; Zhuge H; Volke L; Stab V; Dietz J; Athamneh M; Roos A; Zaehres H; Güttsches AK; Mavrommatis L; Vorgerd M
    Stem Cell Res; 2024 Apr; 76():103320. PubMed ID: 38309149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
    Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
    Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease.
    Kim KP; Yoon J; Shin B; Röpke A; Han DW; Schöler HR
    Stem Cell Res; 2020 Jul; 46():101839. PubMed ID: 32446239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
    Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma.
    Chen K; Zhuang Z; Wang Q; Li K; Xu S; Liu M; Zhang K; Wei L; Zhang Y; Lian H; Zhang B; Zhong C
    Stem Cell Res; 2021 Oct; 56():102546. PubMed ID: 34587579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation.
    Pan Z; Wang H; Wang H; Liu Y; Liang P
    Stem Cell Res; 2021 Aug; 55():102459. PubMed ID: 34298435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.